@article{Tijare_Deshmukh_Mohod_Bhandakkar_Hore_Padole_2022, title={Process Validation of Highly Potent Antidiabetic Tablets of Voglibose 0.2 Mg}, volume={10}, url={https://ajprd.com/index.php/journal/article/view/1070}, DOI={10.22270/ajprd.v10i2.1070}, abstractNote={<p>Diabetes mellitus is chronic disorder which affecting number of persons worldwide, alpha glycoside inhibitors like Voglibose is a highly potent and tolerant alpha glycoside inhibitor as compare to other diabetic drugs, the main objective of this process validation is to provide documentary evidence that the manufacturing process of <strong>Voglibose Tablet IP 0.2 mg </strong>will consistently and reproducibly produce a product, which meets predetermined specifications and quality attributes. The critical process parameter was identified with the help of process capability and evaluated by challenging as per in-house specification.  Three   initial   process validation batches (T17L004, T18L003, T19A013) of same size, method, equipment & validation criteria were taken.  As per the process validation protocol critical parameter identified like sifting, dry mixing, wet granulation, drying, sifting and milling, blending &lubrication, compression at different stages and blister packing and evaluated as per process validation protocol. <strong>Conclusion: </strong>Based on evaluation of manufacturing process and analytical data it is concluded that the employed manufacturing process for <strong>Voglibose </strong><strong>Tablet IP 0.2 mg </strong>shall be consistently& reproducibly produce a product which meeting its predetermined specification and quality attributes, hence it is considered to be validated.</p> <p> </p>}, number={2}, journal={Asian Journal of Pharmaceutical Research and Development}, author={Tijare, Lokesh K. and Deshmukh, Lokesh T. and Mohod, Abhinay A. and Bhandakkar, Vivek M. and Hore, Santosh and Padole, Nitin N.}, year={2022}, month={Apr.}, pages={90–110} }